Stay updated on Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.

Latest updates to the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag, v3.5.4, has been added to the page, replacing the previous v3.5.3. This reflects an updated version of the page metadata rather than a substantive content update.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3, reflecting a frontend or release update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check42 days agoChange Detected- Revision: v3.5.2 updated from the previous v3.5.0.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check107 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check114 days agoChange DetectedThe page shows Revision: v3.4.1, replacing v3.4.0; no changes to study content or functionality are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.